durapatite has been researched along with holmium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balooch, M; Bell, WL; Haupt, DL; Kinney, JH; Marshall, GW; Marshall, SJ; White, JM | 1 |
| Banerjee, S; Chakraborty, S; Das, T; Sarma, HD; Venkatesh, M | 1 |
| da Silva, FMR; de Almeida, JC; de Souza Albernaz, M; Oliveira, EEM; Rossi, AM; Santos-Oliveira, R | 1 |
3 other study(ies) available for durapatite and holmium
| Article | Year |
|---|---|
The threshold effects of Nd and Ho: YAG laser-induced surface modification on demineralization of dentin surfaces.
Topics: Absorption; Crystallization; Dentin; Dentin Permeability; Durapatite; Holmium; Humans; Laser Therapy; Lasers; Neodymium; Porosity; Surface Properties; Tomography, X-Ray; Tooth Demineralization; Water; X-Ray Diffraction | 1996 |
166Ho-labeled hydroxyapatite particles: a possible agent for liver cancer therapy.
Topics: Animals; Disease Models, Animal; Durapatite; Holmium; Injections, Intra-Articular; Liver Neoplasms; Oxides; Radioisotopes; Rats; Rats, Wistar; Tissue Distribution; Whole Body Imaging | 2009 |
Nano-Hydroxyapatite Doped with Ho-166 as Drug Delivery System for Bone Cancer Therapy and Diagnosis: Developing a Theragnostic Radiopharmaceuticals.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Durapatite; Female; Holmium; Male; Molecular Structure; Nanostructures; Radiopharmaceuticals; Rats; Rats, Wistar; Structure-Activity Relationship | 2017 |